LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

1266 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking LINAGLIPTIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 100
1 DIARRHOEA 95
2 NAUSEA 68
3 VOMITING 60
4 DRUG INEFFECTIVE 55
5 OFF LABEL USE 47
6 FATIGUE 46
7 DIZZINESS 44
8 PAIN 44
9 HEADACHE 42
See all common reactions for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTINUCLEAR ANTIBODY 5 0.0316
1 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 6 0.0098
2 ANTIBODY TEST ABNORMAL 6 0.0083
3 LEFT ATRIAL DILATATION 7 0.0055
4 GLOMERULONEPHRITIS MEMBRANOUS 6 0.0051
5 RESPIRATORY ALKALOSIS 7 0.0043
6 MUCOSAL DRYNESS 7 0.0035
7 HAEMATOCRIT INCREASED 7 0.0031
8 IMMUNE-MEDIATED MYOSITIS 8 0.0029
9 SUSPECTED COVID-19 6 0.0018
See all enriched reactions for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE